These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6093522)

  • 1. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone in the treatment of serious infections, particularly after surgery.
    Scully BE; Neu HC
    Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
    Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily cefazolin and probenecid for skin and soft tissue infections.
    Cox VC; Zed PJ
    Ann Pharmacother; 2004 Mar; 38(3):458-63. PubMed ID: 14970368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone for once-a-day therapy of urinary tract infections.
    Childs SJ; Wells WG; Mirelman S
    Am J Med; 1984 Oct; 77(4C):73-6. PubMed ID: 6093524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone therapy of meningitis and serious infections.
    Steele RW
    Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults.
    Grayson ML; McDonald M; Gibson K; Athan E; Munckhof WJ; Paull P; Chambers F
    Clin Infect Dis; 2002 Jun; 34(11):1440-8. PubMed ID: 12015689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic prophylaxis in high-risk biliary operations: multicenter trial of single preoperative ceftriaxone versus multidose cefazolin.
    Kellum JM; Gargano S; Gorbach SL; Talcof C; Curtis LE; Weiner B; McCoobery M; Tan JS; Kelly T; Wagner D
    Am J Surg; 1984 Oct; 148(4A):15-8. PubMed ID: 6091474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone: therapeutic results in various infections and kinetic studies.
    Giamarellou HJ; Tsagarakis J; Petrikkos G; Mavroudis K; Veldekis D; Daikos GK
    Arzneimittelforschung; 1984; 34(3):321-5. PubMed ID: 6329238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
    Chan JC
    Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone versus combined gentamicin and clindamycin for polymicrobial surgical sepsis.
    Stone HH; Mullins RJ; Strom PR; Bourneuf AA; Geheber CE
    Am J Surg; 1984 Oct; 148(4A):30-4. PubMed ID: 6091478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily ceftriaxone for skin and soft tissue infections.
    Gordin FM; Wofsy CB; Mills J
    Antimicrob Agents Chemother; 1985 Apr; 27(4):648-9. PubMed ID: 4004197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient treatment of serious community-acquired pediatric infections using once daily intramuscular ceftriaxone.
    Dagan R; Phillip M; Watemberg NM; Kassis I
    Pediatr Infect Dis J; 1987 Dec; 6(12):1080-4. PubMed ID: 3324038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
    Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
    Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
    Gentry LO; Rodriguez-Gomez G; Zeluff BJ; Khoshdel A; Price M
    Am J Med; 1989 Dec; 87(6C):57S-60S. PubMed ID: 2690621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of ceftriaxone.
    File TM; Tan JS; Salstrom SJ
    Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections].
    Oishi K; Kawakita M; Hida S; Higashi Y; Yamauchi T; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
    Tassler H
    Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.